Home > Insider Trading > Filing (0001354488-13-002288)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
834365	Biolife Solutions Inc	BLFS	Electromedical & Electrotherapeutic Apparatus (3845)	943076866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273547	Thomas Girschweiler	C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway Bothell WA 98021		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2005-12-31	1,761,827	$0.12	2,299,887	No	4	P	Direct
Common Shares	Acquisiton	2006-05-01	479,999	$0.06	13,989,886	No	4	P	Direct
Common Shares	Acquisiton	2007-02-13	416,666	$0.00	14,406,552	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Common Share Warrants	Acquisiton	2010-11-29	1,000,000	$0.00	1,000,000	$0.07
Common Shares	Common Share Warrants	Acquisiton	2011-08-10	1,000,000	$0.00	1,000,000	$0.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,000,000	2010-11-29	2015-11-29	No	4	J	Direct
1,000,000	2011-08-10	2016-08-30	No	4	J	Direct

Footnotes

Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares.
Resulting purchase from cash dividend paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer's common shares.
Total includes 11,210,000 common shares acquired upon conversion of Series F and Series G preferred shares and warrants previously reported on Form 4 filed on April 18, 2006 and 538,060 common shares previously held.
Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010.
Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility?" to $4,750,000 and extending the maturity date to January 11, 2013.
Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility"? to $5,250,000.